Proper determination of LGMD D4 requires western blotting for the calpain-3 protein level in a muscle biopsy as likely only a subset of known (and yet unknown) CAPN3 variants can give rise to the dominant form. The gene discussed is CAPN3; the disease is limb-girdle muscular dystrophy.